摘要
Carlos Chagas发现克氏锥虫(克氏锥虫)为一种被忽视的热带病南美锥虫病的病原体(CD),对社会经济、流行病学和人类健康的影响已经一个多世纪了。目前,只有两种商品化药物硝呋莫司和苄硝唑,治疗急性期CD,存在一些不良的副作用。因此,迫切需要新的口服和安全的药物来治疗这种寄生虫感染。在新的药物发现计划中非常重要的一个策略是基于搜索能够干扰参与克氏锥虫新陈代谢的酶的分子。 该综述将重点关注两种最有希望的治疗CD的锥虫硫酸还原酶(TR)和含铁超氧化物歧化酶(Fe-SOD)的靶标,它们可以保护寄生虫免受活性氧的氧化损伤。本文将讨论其功能,作用机制和T. cruzi TR与Fe-SOD之间的活性位点及其类似物在人类谷胱甘肽还原酶(GR)和相应的SOD中的酶的简要比较。 该综述还将总结报道的新型化合物对选择性抑制这些靶标的能力的最新发展和结构 - 活性关系,旨在确定寻找新的有效治疗CD的分子基础。
关键词: 南美锥虫病、克氏锥虫、锥虫胱甘肽还原酶、超氧化物歧化酶活性、氢溴酸、药物靶点,药物开发,构效关系。
Current Medicinal Chemistry
Title:Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease
Volume: 24 Issue: 11
关键词: 南美锥虫病、克氏锥虫、锥虫胱甘肽还原酶、超氧化物歧化酶活性、氢溴酸、药物靶点,药物开发,构效关系。
摘要: It has been over a century since Carlos Chagas discovered the Trypanosoma cruzi (T. cruzi) as the causative agent of Chagas disease (CD), a neglected tropical disease with several socioeconomic, epidemiological and human health repercussions. Currently, there are only two commercialized drugs to treat CD in acute phase, nifurtimox and benznidazol, with several adverse side effects. Thus, new orally available and safe drugs for this parasitic infection are urgently required. One strategy of great importance in new drug discovery programmes is based on the search of molecules enabling to interfere with enzymes involved in T. cruzi metabolism. This review will focus on two of the most promising targets for the therapy of CD: trypanothione reductase (TR) and the iron-containing superoxide dismutase (Fe- SOD), which protect the parasite against oxidative damage by reactive oxygen species. A brief comparison of the function, mechanism of action and the active sites between T. cruzi TR and Fe-SOD with their analogues enzymes in human, glutathione reductase (GR) and the corresponding SODs, will be discussed. This review will also summarize the recent development and structure-activity relationships of novel compounds reported for their ability to selectively inhibit these targets, aiming to define molecular bases in the search for new effective treatment of CD.
Export Options
About this article
Cite this article as:
Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease, Current Medicinal Chemistry 2017; 24 (11) . https://dx.doi.org/10.2174/0929867323666161227094049
DOI https://dx.doi.org/10.2174/0929867323666161227094049 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Review of Vital Signs Monitoring Systems – Patient’s Acceptability, Issues and Challenges
Neuroscience and Biomedical Engineering (Discontinued) The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Current Vascular Pharmacology Morpho-Functional Features of In-Vitro Cell Death Induced by Physical Agents
Current Pharmaceutical Design The Role of Snail in EMT and Tumorigenesis
Current Cancer Drug Targets The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment
Current Pharmaceutical Design Atherosclerosis-Related Functions of C-Reactive Protein
Cardiovascular & Hematological Disorders-Drug Targets Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome
Current Vascular Pharmacology Heart Failure and Diabetes: Perspective of a Dangerous Association
Current Hypertension Reviews Indications, Implications and Applications of Renal Denervation. Have we Discovered Something new?
Current Hypertension Reviews The Protein-Protein Interaction-Mediated Inactivation of PTEN
Current Molecular Medicine Nitrogen Biobank for Cardiovascular Research
Current Cardiology Reviews New Method of Inhibition of Activity of Tumor Necrosis Factor Alpha In Patients with Psoriasis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Peptide Biomarkers: Exploring the Diagnostic Aspect
Current Protein & Peptide Science Clinical Studies of Renal Nerve Ablation. Unanswered Questions for its Efficacy and Safety
Current Clinical Pharmacology Basal Septal Hypertrophy
Current Cardiology Reviews Expression and Functions of Vasoactive Substances Regulated by Hypoxia-Inducible Factor-1 in Chronic Hypoxemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology The Anticancer Properties of Dietary Polyphenols and its Relation with Apoptosis
Current Pharmaceutical Design Protective Effect of Vitamin B Therapy on Bone and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery